Unknown

Dataset Information

0

Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.


ABSTRACT: Although umbilical cord blood (UCB) hematopoietic stem cell transplantation (UCBT) has emerged as a promising haematological reconstitution therapy for leukemias and other related disorders, the insufficient UCB stem cell dosage still hinders better clinical outcomes. Previous research efforts, by focusing on ex vivo UCB expansion capabilities have sought to benefit from well-known mechanisms of self-renewal characteristics of UCB stem cells. However, the long-term (> 21 days) in vitro culture period and the low neutrophil recovery significantly reduce the transplantability of such ex vivo expanded UCB stem cells. To overcome the latter hurdles in this study, a post-thaw, short-term ex vivo expansion methodology of UCB mononuclear (UCB-MN) and CD34(+) cells has been established. Notably, such effort was achieved through pharmacological preconditioned of UCB cultures by filgrastim agent already used in the clinical setting. In crucial cell populations implicated in the promotion of functional engraftment, the progression of free survival rates (PFS), a marked increase of 6.65 to 9.34 fold for UCB-MN and 35 to 49 fold for CD34(+) cells has been noticed. Overall, these results indicate that transplantation of pharmacologically-preconditioned ex vivo expansion of UCB stem and progenitor cells keep high promise upon transplantation to enhance therapeutic potential in everyday clinical practice.

SUBMITTER: Grigoriadis NG 

PROVIDER: S-EPMC4913295 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.

Grigoriadis Nikolaos G NG   Grigoriadis Ioannis G IG   Markoula Sofia S   Paschopoulos Minas M   Zikopoulos Konstantinos K   Apostolakopoulos Panagiotis Gr PG   Vizirianakis Ioannis S IS   Georgiou Ioannis I  

American journal of stem cells 20160515 1


Although umbilical cord blood (UCB) hematopoietic stem cell transplantation (UCBT) has emerged as a promising haematological reconstitution therapy for leukemias and other related disorders, the insufficient UCB stem cell dosage still hinders better clinical outcomes. Previous research efforts, by focusing on ex vivo UCB expansion capabilities have sought to benefit from well-known mechanisms of self-renewal characteristics of UCB stem cells. However, the long-term (> 21 days) in vitro culture p  ...[more]

Similar Datasets

| S-EPMC5546440 | biostudies-literature
| S-EPMC5905230 | biostudies-literature
| S-EPMC7206416 | biostudies-literature
| S-EPMC4071379 | biostudies-literature
| S-EPMC6496543 | biostudies-literature
| S-EPMC5312371 | biostudies-literature
| S-EPMC3916033 | biostudies-literature
| S-EPMC6138889 | biostudies-literature
| S-EPMC3484967 | biostudies-literature
| S-EPMC3811179 | biostudies-literature